Explore how machine learning and generative AI are revolutionizing small molecule drug discovery—from data-driven design and ADMET prediction to generative models that “imagine” new drugs and reshape modern pharmacology.
Discover how generative AI is transforming small molecule drug discovery by designing novel compounds in silico, optimizing potency and ADMET profiles, and enabling closed-loop discovery cycles across oncology, fibrosis, infectious disease, and CNS disorders.